Article Versions Notes

Genovese D, Brinch D, Muscarella S, Saladino M, Carrozza L, Cunsolo C, Sanfilippo GL, Amodio E, Cappello M, Ferraro D. Neutralizing Antibody Response to SARS-CoV-2 Variants After Two mRNA COVID-19 Vaccine Doses in a Cohort of Patients with Inflammatory Bowel Disease from a Southern Italy Tertiary Hospital. Healthcare. 2025; 13(5):508. https://doi.org/10.3390/healthcare13050508

Genovese, Dario, Daniele Brinch, Stefano Muscarella, Marica Saladino, Lucio Carrozza, Chiara Cunsolo, Giuseppa Luisa Sanfilippo, Emanuele Amodio, Maria Cappello, and Donatella Ferraro. 2025. "Neutralizing Antibody Response to SARS-CoV-2 Variants After Two mRNA COVID-19 Vaccine Doses in a Cohort of Patients with Inflammatory Bowel Disease from a Southern Italy Tertiary Hospital" Healthcare 13, no. 5: 508. https://doi.org/10.3390/healthcare13050508

Genovese, D., Brinch, D., Muscarella, S., Saladino, M., Carrozza, L., Cunsolo, C., Sanfilippo, G. L., Amodio, E., Cappello, M., & Ferraro, D. (2025). Neutralizing Antibody Response to SARS-CoV-2 Variants After Two mRNA COVID-19 Vaccine Doses in a Cohort of Patients with Inflammatory Bowel Disease from a Southern Italy Tertiary Hospital. Healthcare, 13(5), 508. https://doi.org/10.3390/healthcare13050508